+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Netherlands Cold Chain in Food & Pharma Market

  • PDF Icon

    Report

  • 93 Pages
  • October 2025
  • Region: Netherlands
  • Ken Research Private Limited
  • ID: 6210665

Netherlands Cold Chain in Food & Pharma Market valued at USD 6.7 Bn, driven by demand for temperature-sensitive products, e-commerce growth, and tech advancements in logistics.

The Netherlands Cold Chain in Food & Pharma Market is valued at USD 6.7 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for temperature-sensitive products, particularly in the food and pharmaceutical sectors, alongside advancements in logistics technology and infrastructure. The rising consumer awareness regarding food safety and quality, the expansion of e-commerce, and the growth of biopharmaceuticals have further propelled the need for efficient cold chain solutions. Automation, real-time temperature monitoring, and sustainable refrigeration technologies are key trends shaping the market’s evolution.

Key cities such as Amsterdam, Rotterdam, and The Hague dominate the market due to their strategic locations, robust transportation networks, and proximity to major ports. These cities serve as critical logistics hubs, facilitating the efficient distribution of temperature-sensitive goods across Europe and beyond. The presence of leading logistics companies and cold storage facilities in these areas also contributes to their market dominance.

In 2023, the Dutch government implemented regulations mandating stricter temperature control measures for the transportation and storage of pharmaceuticals. The “Good Distribution Practice (GDP) Guidelines for Medicinal Products for Human Use,” issued by the Ministry of Health, Welfare and Sport in accordance with EU Regulation 2013/C 343/01, require all stakeholders to maintain specified temperature ranges, utilize validated monitoring equipment, and ensure full traceability throughout the supply chain. Compliance with these regulations is crucial for companies operating in the cold chain sector, as it directly impacts product safety and efficacy.

Netherlands Cold Chain in Food & Pharma Market Segmentation

By Service Type:

The service type segmentation includes various subsegments such as Storage, Transportation, Packaging, Monitoring & Tracking, and Value-Added Services. Among these, Transportation is the leading subsegment, driven by the increasing demand for efficient logistics solutions and the need for timely delivery of temperature-sensitive products. The rise in e-commerce and online grocery shopping has further fueled the growth of transportation services within the cold chain sector. Storage remains a significant segment due to the expansion of automated and energy-efficient cold warehouses.

By Temperature Range:

The temperature range segmentation includes Chilled, Frozen, and Deep-Frozen subsegments. The Chilled segment is the most significant, driven by the high demand for fresh produce, dairy products, and ready-to-eat meals. The growing consumer preference for fresh and minimally processed foods has led to an increase in chilled storage and transportation solutions, making it a dominant player in the cold chain market. Frozen and deep-frozen segments are also expanding, supported by the rising export of processed foods and seafood.

Netherlands Cold Chain in Food & Pharma Market Competitive Landscape

The Netherlands Cold Chain in Food & Pharma Market is characterized by a dynamic mix of regional and international players. Leading participants such as Lineage Logistics, Kloosterboer, NewCold, STEF Netherlands, DFDS, DHL Supply Chain, A.P. Moller - Maersk, Kuehne + Nagel, DB Schenker, CEVA Logistics, Americold Logistics, H Essers, Frigo Group, Van den Bosch, Nunner Logistics contribute to innovation, geographic expansion, and service delivery in this space.

Netherlands Cold Chain in Food & Pharma Market Industry Analysis

Growth Drivers

Increasing Demand for Temperature-Sensitive Products:

The Netherlands has seen a significant rise in the demand for temperature-sensitive products, particularly in the food and pharmaceutical sectors. In future, the biopharmaceutical market in the Netherlands was valued at approximately €6.1 billion, with projections indicating a growth rate of 6% annually. This surge is driven by the increasing prevalence of chronic diseases and the need for effective temperature-controlled logistics to ensure product integrity and safety throughout the supply chain.

Expansion of E-commerce in Food and Pharma:

E-commerce in the Netherlands has experienced remarkable growth, with online food sales reaching €3.7 billion in future, a 15% increase from the previous year. This trend is further fueled by the rising consumer preference for convenience and home delivery services. As e-commerce continues to expand, the demand for efficient cold chain logistics to maintain product quality during transportation is becoming increasingly critical, driving investments in cold storage and transportation solutions.

Technological Advancements in Cold Chain Logistics:

The cold chain logistics sector in the Netherlands is benefiting from technological advancements, including IoT and automation. In future, investments in cold chain technology reached €1.4 billion, reflecting a 20% increase from the previous year. These innovations enhance tracking, monitoring, and management of temperature-sensitive products, ensuring compliance with stringent regulations and improving operational efficiency, which is essential for maintaining product quality and safety.

Market Challenges

High Operational Costs:

The operational costs associated with cold chain logistics in the Netherlands are notably high, with estimates indicating that logistics expenses account for approximately 12% of total food and pharmaceutical costs. Factors contributing to these costs include energy consumption, maintenance of refrigeration equipment, and labor expenses. As energy prices fluctuate, maintaining profitability while ensuring compliance with temperature control standards poses a significant challenge for operators in this sector.

Infrastructure Limitations:

Despite the advanced logistics network in the Netherlands, infrastructure limitations remain a challenge. In future, it was reported that only 65% of cold storage facilities met the latest technological standards. This gap can lead to inefficiencies in the supply chain, increased spoilage rates, and difficulties in meeting the growing demand for temperature-sensitive products. Upgrading existing infrastructure is essential to enhance capacity and reliability in cold chain operations.

Netherlands Cold Chain in Food & Pharma Market Future Outlook

The future of the cold chain logistics market in the Netherlands appears promising, driven by ongoing technological advancements and increasing consumer demand for temperature-sensitive products. As the biopharmaceutical sector continues to expand, the need for efficient cold chain solutions will intensify. Additionally, the integration of sustainable practices and IoT technologies is expected to enhance operational efficiency, reduce costs, and improve traceability, positioning the Netherlands as a leader in cold chain logistics within Europe.

Market Opportunities

Growth in Biopharmaceuticals:

The biopharmaceutical sector presents a significant opportunity for cold chain logistics, with the market projected to grow to €8 billion by future. This growth is driven by the increasing demand for biologics and personalized medicine, necessitating robust cold chain solutions to ensure product integrity and compliance with regulatory standards.

Adoption of IoT in Cold Chain Management:

The adoption of IoT technologies in cold chain management is expected to revolutionize the industry. In future, it is anticipated that 45% of cold chain operators will implement IoT solutions, enhancing real-time monitoring and data analytics capabilities. This shift will improve operational efficiency, reduce waste, and ensure compliance with stringent temperature control regulations.

Table of Contents

1. Netherlands Cold Chain in Food & Pharma Market Overview
1.1. Definition and Scope
1.2. Market Taxonomy
1.3. Market Growth Rate
1.4. Market Segmentation Overview
2. Netherlands Cold Chain in Food & Pharma Market Size (in USD Bn), 2019-2024
2.1. Historical Market Size
2.2. Year-on-Year Growth Analysis
2.3. Key Market Developments and Milestones
3. Netherlands Cold Chain in Food & Pharma Market Analysis
3.1. Growth Drivers
3.1.1 Increasing Demand for Temperature-Sensitive Products
3.1.2 Expansion of E-commerce in Food and Pharma
3.1.3 Stringent Regulatory Requirements
3.1.4 Technological Advancements in Cold Chain Logistics
3.2. Restraints
3.2.1 High Operational Costs
3.2.2 Infrastructure Limitations
3.2.3 Compliance with Regulatory Standards
3.2.4 Fluctuating Energy Prices
3.3. Opportunities
3.3.1 Growth in Biopharmaceuticals
3.3.2 Adoption of IoT in Cold Chain Management
3.3.3 Increasing Focus on Sustainability
3.3.4 Expansion into Emerging Markets
3.4. Trends
3.4.1 Rise of Automated Cold Storage Solutions
3.4.2 Integration of Blockchain for Traceability
3.4.3 Shift Towards Multi-Temperature Warehousing
3.4.4 Growing Consumer Awareness of Food Safety
3.5. Government Regulation
3.5.1 EU Food Safety Regulations
3.5.2 Dutch Cold Chain Logistics Standards
3.5.3 Environmental Regulations on Refrigerants
3.5.4 Compliance with GDP Guidelines for Pharmaceuticals
3.6. SWOT Analysis
3.7. Stakeholder Ecosystem
3.8. Competition Ecosystem
4. Netherlands Cold Chain in Food & Pharma Market Segmentation, 2024
4.1. By Service Type (in Value %)
4.1.1 Storage
4.1.2 Transportation
4.1.3 Packaging
4.1.4 Monitoring & Tracking
4.1.5 Value-Added Services
4.2. By Temperature Range (in Value %)
4.2.1 Chilled
4.2.2 Frozen
4.2.3 Deep-Frozen
4.3. By End-User (in Value %)
4.3.1 Food & Beverage
4.3.2 Pharmaceuticals & Life Sciences
4.3.3 Biotechnology
4.3.4 Healthcare
4.3.5 Others
4.4. By Application (in Value %)
4.4.1 Fruits & Vegetables
4.4.2 Dairy Products
4.4.3 Fish, Meat & Seafood
4.4.4 Processed Food
4.4.5 Pharmaceuticals (incl. Vaccines, Blood Banking)
4.4.6 Others
4.5. By Distribution Mode (in Value %)
4.5.1 Road
4.5.2 Sea
4.5.3 Rail
4.5.4 Air
4.6. By Facility Type (in Value %)
4.6.1 Refrigerated Warehouse
4.6.2 Cold Room
4.6.3 Blast Freezer
4.6.4 Walk-in Cooler/Freezer
4.6.5 Others
5. Netherlands Cold Chain in Food & Pharma Market Cross Comparison
5.1. Detailed Profiles of Major Companies
5.1.1 Lineage Logistics
5.1.2 Kloosterboer
5.1.3 NewCold
5.1.4 STEF Netherlands
5.1.5 DFDS
5.2. Cross Comparison Parameters
5.2.1 Revenue (EUR, latest year)
5.2.2 Market Share (%)
5.2.3 Number of Temperature-Controlled Facilities
5.2.4 Total Cold Storage Capacity (cubic meters or pallet positions)
5.2.5 Fleet Size (Refrigerated Vehicles/Containers)
6. Netherlands Cold Chain in Food & Pharma Market Regulatory Framework
6.1. Compliance Requirements and Audits
6.2. Certification Processes
7. Netherlands Cold Chain in Food & Pharma Market Future Size (in USD Bn), 2025-2030
7.1. Future Market Size Projections
7.2. Key Factors Driving Future Market Growth
8. Netherlands Cold Chain in Food & Pharma Market Future Segmentation, 2030
8.1. By Service Type (in Value %)
8.2. By Temperature Range (in Value %)
8.3. By End-User (in Value %)
8.4. By Application (in Value %)
8.5. By Distribution Mode (in Value %)
8.6. By Facility Type (in Value %)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Lineage Logistics
  • Kloosterboer
  • NewCold
  • STEF Netherlands
  • DFDS
  • DHL Supply Chain
  • A.P. Moller - Maersk
  • Kuehne + Nagel
  • DB Schenker
  • CEVA Logistics
  • Americold Logistics
  • H Essers
  • Frigo Group
  • Van den Bosch
  • Nunner Logistics